Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $972.93 | 53 | 96.9% |
| Education | $31.49 | 1 | 3.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Pharmaceuticals, Inc | $140.74 | 4 | $0 (2019) |
| Novartis Pharmaceuticals Corporation | $130.08 | 6 | $0 (2022) |
| Novo Nordisk Inc | $78.42 | 4 | $0 (2024) |
| ABBVIE INC. | $74.52 | 4 | $0 (2024) |
| Astellas Pharma US Inc | $69.08 | 3 | $0 (2023) |
| GlaxoSmithKline, LLC. | $64.56 | 4 | $0 (2024) |
| Merck Sharp & Dohme Corporation | $60.34 | 4 | $0 (2017) |
| SANOFI-AVENTIS U.S. LLC | $51.75 | 3 | $0 (2017) |
| Exact Sciences Corporation | $43.66 | 2 | $0 (2023) |
| Otsuka America Pharmaceutical, Inc. | $42.17 | 3 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $58.91 | 3 | Novo Nordisk Inc ($21.94) |
| 2023 | $227.35 | 12 | GlaxoSmithKline, LLC. ($48.37) |
| 2022 | $54.92 | 2 | Astellas Pharma US Inc ($31.49) |
| 2021 | $41.17 | 2 | SUN PHARMACEUTICAL INDUSTRIES INC. ($24.46) |
| 2019 | $168.23 | 10 | Novartis Pharmaceuticals Corporation ($86.43) |
| 2018 | $236.11 | 10 | Janssen Pharmaceuticals, Inc ($99.85) |
| 2017 | $217.73 | 15 | Merck Sharp & Dohme Corporation ($60.34) |
All Payment Transactions
54 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 02/15/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $16.19 | General |
| Category: RESPIRATORY | ||||||
| 02/01/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $21.94 | General |
| Category: Obesity | ||||||
| 01/05/2024 | ABBVIE INC. | SYNTHROID (Drug) | Food and Beverage | In-kind items and services | $20.78 | General |
| Category: IMMUNOLOGY | ||||||
| 12/11/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $13.57 | General |
| Category: RESPIRATORY | ||||||
| 11/02/2023 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $18.07 | General |
| Category: Oncology | ||||||
| 10/27/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $19.14 | General |
| Category: RESPIRATORY | ||||||
| 10/12/2023 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $15.55 | General |
| Category: NEUROSCIENCE | ||||||
| 10/09/2023 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $25.59 | General |
| Category: Oncology | ||||||
| 09/29/2023 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $18.96 | General |
| Category: Diabetes | ||||||
| 08/16/2023 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $23.52 | General |
| Category: Diabetes | ||||||
| 07/24/2023 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $12.71 | General |
| Category: Biological | ||||||
| 07/20/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $15.66 | General |
| Category: RESPIRATORY | ||||||
| 06/23/2023 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $24.88 | General |
| Category: Biological | ||||||
| 05/25/2023 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $21.48 | General |
| Category: NEUROSCIENCE | ||||||
| 04/27/2023 | Xeris Pharmaceuticals, Inc. | GVOKE HYPOPEN (Drug) | Food and Beverage | In-kind items and services | $18.22 | General |
| Category: Diabetes | ||||||
| 09/07/2022 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $23.43 | General |
| Category: CARDIOVASCULAR | ||||||
| 02/15/2022 | Astellas Pharma US Inc | — | Education | In-kind items and services | $31.49 | General |
| 06/24/2021 | SUN PHARMACEUTICAL INDUSTRIES INC. | KAPSPARGO (Drug), EZALLOR SPRINKLE, DRIZALMA SPRINKLE | Food and Beverage | In-kind items and services | $24.46 | General |
| Category: Cardiology Vascular Diseases | ||||||
| 05/26/2021 | AbbVie Inc. | TEFLARO (Drug) | Food and Beverage | In-kind items and services | $16.71 | General |
| Category: ANTI-INFECTIVE | ||||||
| 12/11/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $14.85 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 11/20/2019 | Allergan Inc. | DALVANCE (Drug) | Food and Beverage | In-kind items and services | $10.98 | General |
| Category: ANTI-INFECTIVE | ||||||
| 10/23/2019 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $24.12 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/16/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $11.22 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 09/04/2019 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $21.98 | General |
| Category: CARDIOVASCULAR | ||||||
| 07/24/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $14.82 | General |
| Category: Cardiovascular & Metabolism | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 11 | 751 | 956 | $259,227 | $89,717 |
| 2022 | 14 | 770 | 1,020 | $279,869 | $100,614 |
| 2021 | 13 | 521 | 643 | $157,297 | $59,451 |
| 2020 | 11 | 368 | 455 | $98,259 | $37,916 |
All Medicare Procedures & Services
52 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 253 | 435 | $117,156 | $40,108 | 34.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 196 | 196 | $77,482 | $25,731 | 33.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 110 | 130 | $23,900 | $7,727 | 32.3% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 18 | 18 | $7,110 | $5,078 | 71.4% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2023 | 29 | 29 | $16,280 | $4,862 | 29.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 26 | 26 | $10,010 | $2,474 | 24.7% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 45 | 45 | $2,295 | $1,412 | 61.5% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 14 | 15 | $1,965 | $1,076 | 54.7% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 29 | 30 | $1,530 | $941.10 | 61.5% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 18 | 19 | $441.00 | $180.88 | 41.0% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 13 | 13 | $1,058 | $129.36 | 12.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 249 | 466 | $124,888 | $44,288 | 35.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 136 | 136 | $54,400 | $18,313 | 33.7% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2022 | 52 | 52 | $31,200 | $8,956 | 28.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 102 | 126 | $22,932 | $7,826 | 34.1% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2022 | 26 | 26 | $10,270 | $7,241 | 70.5% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2022 | 12 | 13 | $9,542 | $2,988 | 31.3% |
| 99305 | Initial nursing facility visit per day, typically 35 minutes | Office | 2022 | 24 | 24 | $4,121 | $2,496 | 60.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 24 | 24 | $9,921 | $2,430 | 24.5% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 47 | 47 | $2,397 | $1,439 | 60.0% |
| G0009 | Administration of pneumococcal vaccine | Office | 2022 | 46 | 46 | $2,346 | $1,411 | 60.2% |
| 99309 | Follow-up nursing facility visit per day, typically 25 minutes | Office | 2022 | 14 | 19 | $2,301 | $1,253 | 54.5% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 15 | 15 | $1,965 | $1,028 | 52.3% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 12 | 12 | $3,264 | $810.30 | 24.8% |
| 83036 | Hemoglobin a1c level | Office | 2022 | 11 | 14 | $322.00 | $134.12 | 41.7% |
About Dr. Sumaira Ali, M.D
Dr. Sumaira Ali, M.D is a Internal Medicine healthcare provider based in Westerly, Rhode Island. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/22/2006. The National Provider Identifier (NPI) number assigned to this provider is 1841236270.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Sumaira Ali, M.D has received a total of $1,004 in payments from pharmaceutical and medical device companies, with $58.91 received in 2024. These payments were reported across 54 transactions from 19 companies. The most common payment nature is "Food and Beverage" ($972.93).
As a Medicare-enrolled provider, Ali has provided services to 2,410 Medicare beneficiaries, totaling 3,074 services with total Medicare billing of $287,697. Data is available for 4 years (2020–2023), covering 52 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Westerly, RI
- Active Since 06/22/2006
- Last Updated 09/18/2020
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1841236270
Products in Payments
- XARELTO (Drug) $140.74
- ENTRESTO (Drug) $130.08
- TRELEGY ELLIPTA (Drug) $64.56
- ELIQUIS (Drug) $45.10
- Cologuard Collection Kit (Device) $43.66
- SAMSCA (Drug) $42.17
- Veozah (Drug) $37.59
- UBRELVY (Drug) $37.03
- LANTUS (Drug) $36.32
- TEFLARO (Drug) $32.80
- STIOLTO (Drug) $32.36
- PNEUMOVAX 23 (Biological) $30.03
- KYPHON Balloon Kyphoplasty (Device) $28.52
- KAPSPARGO (Drug) $24.46
- Rybelsus (Drug) $23.52
- Wegovy (Drug) $21.94
- SYNTHROID (Drug) $20.78
- Ozempic (Drug) $18.96
- GVOKE HYPOPEN (Drug) $18.22
- MOVANTIK (Drug) $15.68
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Westerly
Vindhya Sriramoju, Md, MD
Internal Medicine — Payments: $2,644
Dr. Lisa Noyes-Duguay, M.d, M.D
Internal Medicine — Payments: $1,892
Dr. James Stuart, Do, DO
Internal Medicine — Payments: $506.72
Peter Bolton, M.d, M.D
Internal Medicine — Payments: $475.69
Ahmed Elshazly, Md, MD
Internal Medicine — Payments: $456.42
Paula Watts-Wojcik, Do, DO
Internal Medicine — Payments: $303.44